World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
74
Citations
22436
World Ranking
2044
National Ranking
1000

Lanying Du publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Lanying Du sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 173 publications — 24th percentile

24% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Lanying Du D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Lanying Du sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 74 D-Index — 59th percentile

59% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Lanying Du is affiliated with Georgia State University in the United States and has contributed extensively to the field of medicine, particularly focusing on infectious diseases and related molecular biology disciplines. Their research spans a variety of subfields including animal science, plant science, and imaging techniques related to radiology and nuclear medicine.

Their recent scholarly work includes numerous publications centered on viral infections and immunology. Notable papers authored or coauthored by Du include:

  • Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine, 2020, Cellular and Molecular Immunology
  • Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion, 2020, Cell Research
  • Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses, 2020, Trends in Immunology
  • Recent advances in the detection of respiratory virus infection in humans, 2020, Journal of Medical Virology
  • Subunit Vaccines Against Emerging Pathogenic Human Coronaviruses, 2020, Frontiers in Microbiology

The main topics of Du's research contributions include:

  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • Animal Virus Infections Studies
  • Viral gastroenteritis research and epidemiology
  • Monoclonal and Polyclonal Antibodies Research
  • Bacteriophages and microbial interactions
  • Immunotherapy and Immune Responses

Lanying Du frequently collaborates with other researchers such as Shibo Jiang, Stanley Perlman, Wanbo Tai, Xiujuan Zhang, and Fang Li, with coauthorship counts reflecting multiple joint projects.

Their research is frequently published in established scientific journals and venues, including:

  • Cellular and Molecular Immunology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Vaccines
  • Trends in Immunology
  • Microbes and Infection

Their body of work predominantly falls under medicine with a strong emphasis on infectious diseases, supported by contributions in molecular biology and animal science domains. This multidisciplinary approach informs their studies on viral pathogens and immune responses.

Best Publications

  • The spike protein of SARS-CoV — a target for vaccine and therapeutic development

    Lanying Du;Yuxian He;Yusen Zhou;Shuwen Liu

  • Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine.

    Wanbo Tai;Lei He;Xiujuan Zhang;Jing Pu;Jing Pu

  • Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion.

    Shuai Xia;Meiqin Liu;Chao Wang;Wei Xu

  • Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses.

    Shibo Jiang;Shibo Jiang;Christopher Hillyer;Lanying Du

  • Molecular mechanism for antibody-dependent enhancement of coronavirus entry

    Yushun Wan;Jian Shang;Shihui Sun;Wanbo Tai

  • Recent advances in the detection of respiratory virus infection in humans

    Naru Zhang;Lili Wang;Xiaoqian Deng;Ruiying Liang

  • A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike

    Shuai Xia;Lei Yan;Wei Xu;Anurodh Shankar Agrawal

  • Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor

    Lu Lu;Qi. Liu;Yun Zhu;Kwok-Hung Chan

  • Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China.

    Fei Yu;Lanying Du;David M. Ojcius;Chungen Pan

  • Subunit Vaccines Against Emerging Pathogenic Human Coronaviruses

    Ning Wang;Jian Shang;Shibo Jiang;Shibo Jiang;Lanying Du

  • An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies

    Shibo Jiang;Shibo Jiang;Lanying Du;Zhengli Shi

  • Severe acute respiratory syndrome-associated coronavirus 3a protein forms an ion channel and modulates virus release

    Wei Lu;Bo-Jian Zheng;Ke Xu;Wolfgang Schwarz

  • MERS-CoV spike protein: a key target for antivirals

    Lanying Du;Yang Yang;Yusen Zhou;Lu Lu

  • Receptor usage and cell entry of bat coronavirus HKU4 provide insight into bat-to-human transmission of MERS coronavirus

    Yang Yang;Lanying Du;Chang Liu;Lili Wang

  • Receptor Usage and Cell Entry of Porcine Epidemic Diarrhea Coronavirus

    Chang Liu;Jian Tang;Yuanmei Ma;Xueya Liang

  • Exceptionally potent neutralization of Middle East respiratory syndrome coronavirus by human monoclonal antibodies.

    Tianlei Ying;Lanying Du;Tina W. Ju;Ponraj Prabakaran

  • Identification of a Receptor-Binding Domain in the S Protein of the Novel Human Coronavirus Middle East Respiratory Syndrome Coronavirus as an Essential Target for Vaccine Development

    Lanying Du;Guangyu Zhao;Zhihua Kou;Cuiqing Ma

  • Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses: (Trends in Immunology 41, 355-359; 2020).

    Shibo Jiang;Christopher Hillyer;Lanying Du

  • A Truncated Receptor-Binding Domain of MERS-CoV Spike Protein Potently Inhibits MERS-CoV Infection and Induces Strong Neutralizing Antibody Responses: Implication for Developing Therapeutics and Vaccines

    Lanying Du;Zhihua Kou;Cuiqing Ma;Xinrong Tao

  • Blockade of the C5a-C5aR axis alleviates lung damage in hDPP4-transgenic mice infected with MERS-CoV

    Yuting Jiang;Guangyu Zhao;Nianping Song;Pei Li

Frequent Co-Authors

Shibo Jiang
Shibo Jiang Fudan University
Yusen Zhou
Yusen Zhou Zhengzhou University
Lu Lu
Lu Lu Fudan University
Chien Te K. Tseng
Chien Te K. Tseng The University of Texas Medical Branch at Galveston
Bo-Jian Zheng
Bo-Jian Zheng University of Hong Kong
Fang Li
Fang Li University of Minnesota
Sara Lustigman
Sara Lustigman New York Blood Center
Yuxian He
Yuxian He Peking Union Medical College Hospital
Peter J. Hotez
Peter J. Hotez Baylor College of Medicine
Maria Elena Bottazzi
Maria Elena Bottazzi Baylor College of Medicine

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing Immunology opens doors to diverse healthcare roles, many of which can be enhanced through related nursing and specialized programs. For those interested in clinical practice with streamlined entry, exploring lpn programs with easiest admission requirements can be a practical step. These programs provide foundational nursing skills essential for patient care.

Advancing to more autonomous roles like a Family Nurse Practitioner is another promising path. Those seeking flexibility often look for the easiest fnp program, which balances accessibility with comprehensive training for primary care.

For professionals interested in mental health, online advanced practice programs are valuable. The best psychiatric mental health nurse practitioner programs online emphasize strong clinical placements, critical for hands-on experience in psychiatric care.

Cost is also a major consideration for many students. Finding the cheapest psychiatric nurse practitioner programs can make specialized education more accessible without sacrificing quality.

Exploring these options can help immunology students and professionals plan strategic educational pathways aligned with their career goals.

Best Scientists Citing Lanying Du

Trending Scientists

Recently Published Articles